Burkholderia cepacia complex nosocomial outbreaks in India: A scoping review. [PDF]
Saran A +5 more
europepmc +1 more source
Convergence of Hypervirulence and Multidrug-Resistance in Burkholderia cepacia Complex Isolates from Patients with COVID-19. [PDF]
Du M +6 more
europepmc +1 more source
Burkholderia cepacia Endocarditis in a Patient With Severe Mitral Annular Calcification. [PDF]
Pepe V, Afari H, O'Quinn RP, Arjoon R.
europepmc +1 more source
Elucidating the synergistic role of hybrid peptide from Burkholderia cepacia enzymes in biodegradation of polycyclic aromatic hydrocarbons. [PDF]
Naveed M +7 more
europepmc +1 more source
Volatile dimethyl disulphide emission from Burkholderia cepacia LS-044 suppresses metabolism and budding in caspofungin-resistant Nakaseomyces glabratus NT2. [PDF]
Rahmath NAK, Lin SY, Young CC, Hameed A.
europepmc +1 more source
Related searches:
The Multifarious, Multireplicon Burkholderia cepacia Complex
Nature Reviews Microbiology, 2005The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but phenotypically similar bacteria that are divided into at least nine species. Bcc bacteria are found throughout the environment, where they can have both beneficial and detrimental effects on plants and some members can also degrade natural and man-made pollutants.
Eshwar Mahenthiralingam +2 more
exaly +3 more sources
Taxonomy and Pathogenesis of the Burkholderia cepacia Complex
Patients with cystic fibrosis (CF) are susceptible to chronic respiratory infection with a number of bacterial pathogens. The Burkholderia cepacia complex bacteria are problematic CF pathogens because (i) they are very resistant to antibiotics, making respiratory infection difficult to treat and eradicate; (ii) infection with these bacteria is ...
Eshwar Mahenthiralingam, Peter Vandamme
exaly +3 more sources
Burkholderia cepacia: This Decision Is Overdue
PDA Journal of Pharmaceutical Science and Technology, 2011This is the third in a series of seven articles discussing the Recall Root Cause Research project conducted by the Division of Manufacturing and Product Quality, Center for Drug Evaluation and Research. This paper reviews the regulatory and scientific impact of a common and recurring opportunistic pathogen, Burkholderia cepacia. B. cepacia is comprised
Lynn, Torbeck +4 more
openaire +2 more sources
Lipopolysaccharide chemotypes of Burkholderia cepacia
Journal of Medical Microbiology, 1999Burkholderia cepacia is an important pathogen in patients with cystic fibrosis (CF) and much is now known of its epidemiology. In contrast, its virulence mechanisms are poorly understood. The lipopolysaccharide (LPS) of B. cepacia, a well-recognised virulence factor of other gram-negative bacteria, is known to be strongly endotoxic in vitro. The aim of
Elwyn, Evans +2 more
openaire +2 more sources

